本文關(guān)鍵詞：甲狀旁腺腫瘤及增生的臨床病理學(xué)研究進(jìn)展，由筆耕文化傳播整理發(fā)布。

甲狀旁腺腫瘤及增生的臨床病理學(xué)研究進(jìn)展

摘要：組織病理學(xué)檢查能確定甲狀旁腺亢進(jìn)癥的病理類(lèi)型,是鑒別甲狀旁腺增生、甲狀旁腺腺瘤和甲狀旁腺癌的經(jīng)典方法。近年來(lái),甲狀旁腺腫瘤及增生的免疫組織化學(xué)標(biāo)記、分子病理學(xué)研究進(jìn)展迅速,研究包括Cyc lin D1,MEN1,HRPT2和CaSR基因與蛋白。臨床影像學(xué)技術(shù)的發(fā)展使甲狀旁腺疾病的術(shù)前診斷更為準(zhǔn)確,術(shù)中測(cè)定的甲狀旁腺激素水平可作為評(píng)估手術(shù)療效的指標(biāo)。
Histopathological examination can determine the pathological types of hyperparathyroidism,which is a classical method to differentiate among parathyroid hyperplasia,parathyroid adenoma and parathyroid carcinoma.In recent years,there has been rapid progress in research of immunohistochemical labelling and molecular pathology of parathyroid tumors and hyperplasia,including Cyclin D1,MEN1,HRPT2 and CaSR gene and protein.The development of clinical imaging techniques makes the preoperative diagnosis of parathyroid diseases more accurate,and the parathyroid hormone levels measured during operation may serve as parameters for evaluation of surgical outcomes.

  本文關(guān)鍵詞：甲狀旁腺腫瘤及增生的臨床病理學(xué)研究進(jìn)展，由筆耕文化傳播整理發(fā)布。